Biotech China 2014

Profile Details
Antoni Ribas
Affiliations:

UCLA Medical Center, UCLA School of Medicine



University of California, Los Angeles
Associate Professor
Hematology and Oncology

 
11-954 Factor Building, 10833 Le Conte Avenue
Los Angeles, CA 90095 US
Phone: 310-206-3928
Fax: 310-206-0914
My Blogs:
 
Age:
Bio:
 
Specialty:
Hematology, Oncology.
 
Presented at Events Covering:
Antibodies, Autoimmunity, Biology, Biotechnology, Cancer Biology, Cell Biology, Dermatology/ Venereology, Epidemiology, Genomics, Hematology, Hepatology, Histology, Immunology, Internal Medicine, Leukemia, Microscopy, Molecular Biology, Monoclonal, Oncology, Peptides, Pharmacology, Proteomics, Stem Cells, Surgery, Translational Research
 
Areas of Interest:
 
Hobbies:
 
General Comments:
BSN Rank: 64 / 2696 (What's this?)
Accomplish Score: 3136
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 93
We'll Post Your CV for Free!
 
 
Speaking/Presenting-Abstract/Poster at Mtg: 118 (1536 / 0)
 
Honors and Awards: 11 (110 / 0)
  • Elected member (2009)
  • New Faculty Award (2008)
  • 2007 Mary Key Ash Foundation award. (2007)
 
Clinical Trial Activity: 0 (0 / 0)
 
Grant Support: 35 (315 / 0)
  • Prostate Cancer grant reviewer. (2010)
  • Academic Training in Medical Oncology (2009 - 2010)
  • The Clinical Fundamental Immunology Training Grant (2006 - 2010)
 
Patents Pending: 4 (32 / 0)
  • MART-1 T Cell Receptors for the Treatment of Cancer (2010)
  • Nucleic Acid Tetramers for High Efficiency Multiplexed Cell Sorting (2010)
  • Cancer Targeting through ROBO4 (2010)
 
Journal - Editor/Reviewer: 0 (0 / 0)
 
Peer Reviewed Papers, Books, Chapters: 105 (630 / 0)
  • Differential Sensitivity of Melanoma Cell Lines with BRAF V600E Mutation to the Specific BRAF Inhibitor PLX4032/RG7204. (2010)
  • MHC-I restricted Melanoma Antigen Specific TCR Engineered Human CD4+ T Cells Are Multifunctional and Help CD8+ Cytolytic T Lymphocyte Expansion, in vitro (2010)
  • Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles (2010)
 
Pre/Non Reviewed Papers, Proceedings: 122 (488 / 0)
  • Overcoming barriers to programming a therapeutic cellular immune response to fight melanoma (2010)
  • Two Kinetic Phases of Distribution and Tumor Targeting by Adoptively Transferred T Cell Receptor Engineered Lymphocytes Inducing Robust Antitumor Responses. (2010)
  • CD40 Expression by Melanocytic Lesions and Melanoma Cell Lines and Direct CD40 Targeting with the Therapeutic Anti-CD40 Antibody CP-870,893 (2010)
 
Membership in Professional Societies: 8 (24 / 0)
  • National Cancer Institute (2010 - Present)
  • American Society of Clinical Investigation (ASCI). (2009 - Present)
  • International Society of Biological Therapy for Cancer (iSBTc). (2006 - Present)
 
White Papers: 0 (0 / 0)
 
Registered on BiotechScienceNews: 1

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.